Robert L. Nussbaum, Chief Medical Officer at Invitae Corp (NVTA), sold 6,098 shares at $3.81 ($23K) on 2022-05-17, disclosed to the SEC on 2022-05-19.
Seasonal sale ($23k) by Chief Medical Officer — this insider has traded NVTA in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NVTA | SELL | 2023-03-15 | $4K | — | Filing → |
| NVTA | SELL | 2022-08-18 | $32K | — | Filing → |
| NVTA | SELL | 2022-03-16 | $262K | — | Filing → |